Disclosure Of Entity's Operating Segments [Text Block]

Neurones S.A. - Filing #5981664

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)	—	—	—	—	—	—	—	24 882 EUR	—	—	—	—	22 183 EUR	—	—	—	—	—	—	—
Profit (loss) before tax	—	—	—	—	—	—	—	88 110 EUR	—	—	—	—	80 765 EUR	—	—	—	—	—	—	—
Profit (loss) from continuing operations	—	—	—	—	—	—	—	63 228 EUR	—	—	—	—	58 582 EUR	—	—	—	—	—	—	—
Profit (loss)	- EUR	52 556 EUR	- EUR	52 556 EUR	- EUR	- EUR	10 672 EUR	63 228 EUR	- EUR	—	- EUR	- EUR	58 582 EUR	—	49 410 EUR	49 410 EUR	9 172 EUR	- EUR	- EUR	- EUR
Assets	—	—	—	—	—	—	—	—	—	725 691 EUR	—	—	—	676 100 EUR	—	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	—	—	—	—	84 382 EUR	—	—	—	—	72 075 EUR	—	—	—	—	—	—	—
Cash flows from (used in) investing activities	—	—	—	—	—	—	—	19 691 EUR	—	—	—	—	21 568 EUR	—	—	—	—	—	—	—
Cash flows from (used in) financing activities	—	—	—	—	—	—	—	34 480 EUR	—	—	—	—	27 060 EUR	—	—	—	—	—	—	—